Abstract
The second year of the COVID-19 (SARS-CoV-2) pandemic in the United States witnessed the widespread availability of effective vaccines and a new presidential administration promising a more coherent and science-based approach. Despite this, the US in 2021 also experienced a continued series of waves in infection and mortality, driven in part by the emergence of the more transmittable Delta and Omicron variants. As was the case in 2020, the magnitude of per-capita infection and mortality varied substantially between states in 2021. State vaccination rates also showed appreciable geographic variations and were significantly negatively correlated with infection rates and strongly so with death rates. Wave severity through 2021 differed somewhat across climatic zones, consistent with weather-induced behavioral changes influencing transmission. Political orientation appears to be an important factor contributing to geographic variations in the pandemic. In particular, the percentage of voters who supported the Republican presidential candidate in the 2020 election was strongly negatively correlated with states’ vaccination rates and positively correlated with death rates. The political divide on vaccination contributes to interstate geographic differences in the outcomes of the pandemic and poses an ongoing challenge to combating COVID-19 in the United States.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Sometimes referred to as the red/blue divide (Kates et al., 2021) because of the commonly applied informal reference to Republican leaning states as ‘red states’ and Democrat leaning states as ‘blue states’.
References
Abdullah, F., Myers, J., Basu, D., Tintinger, G., Ueckermann, V., Mathebula, M., Ramlall, R., Spoor, S., de Villiers, T., Van der Walt, Z., & Cloete, J. (2021). Decreased severity of disease during the first global omicron variant Covid-19 outbreak in a large hospital in Tshwane, South Africa. International Journal of Infectious Diseases, 116, 38–42.
Alexandar, S., Ravisankar, M., Kumar, R. S., & Jakkan, K. (2021). A comprehensive review on Covid-19 Delta variant. International Journal of Pharmacology and Clinical Research (IJPCR), 5, 83–85.
Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O’Connell, A. M., & Simons, D., et al. (2021). Effectiveness of COVID-19 vaccines against the Omicron (B. 1.1. 529) variant of concern. MedRxiv. 2021 Dec 14. https://khub.net/documents/135939561/430986542/Effectiveness+of+COVID-19+vaccines+against+Omicron+variant+of+concern.pdf/f423c9f4-91cb-0274-c8c5-70e8fad50074
Bergquist, S., Otten, T., & Sarich, N. (2020). COVID-19 pandemic in the United States. Health Policy and Technology, 9, 623–638.
CDC (Centers for Disease Control and Prevention). (2022). COVID data tracker (CDC: https://data.cdc.gov/Case-Surveillance/United-States-COVID-19-Cases-and-Deaths-by-State-o/9mfq-cb36 ; https://covid.cdc.gov/covid-data-tracker/#trends_dailycases_totalvaccinesadministered; https://covid.cdc.gov/covid-data-tracker/#trends_dailydeaths_totalvaccinesadministered; https://covid.cdc.gov/covid-data-tracker/#rates-by-vaccine-status; https://covid.cdc.gov/covid-data-tracker/#datatracker-home. Accessed January, 13–31, 2022.
CDC (Centers for Disease Control and Prevention) COVID-19 Response Team. (2021). SARS-CoV-2 B. 1.1. 529 (Omicron) variant—United States, December 1–8, 2021. Morbidity and Mortality Weekly Report, 70, 1731.
Corcoran, K. E., Scheitle, C. P., & DiGregorio, B. D. (2021). Christian nationalism and COVID-19 vaccine hesitancy and uptake. Vaccine, 39, 6614–6621.
Coustasse, A., Kimble, C., & Maxik, K. (2021). COVID-19 and vaccine hesitancy: A challenge the United States must overcome. The Journal of Ambulatory Care Management, 44, 71–75.
Del Rio, C., Malani, P. N., & Omer, S. B. (2021). Confronting the delta variant of SARS-CoV-2, summer 2021. JAMA, 326, 1001–1002.
Eyre, D. W., Taylor, D., Purver, M., Chapman, D., Fowler, T., Pouwels, K. B., Walker, A. S., & Peto, T. E. (2022). Effect of Covid-19 vaccination on transmission of Alpha and Deltavariants. New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2116597
Federal Elections Commission. (2020). Official 2020 presidential general election results. https://www.fec.gov/resources/cms-content/documents/2020presgeresults.pdf
Fridman, A., Gershon, R., & Gneezy, A. (2021). COVID-19 and vaccine hesitancy: A longitudinal study. PLoS ONE, 16, e0250123.
Gao, J., & Radford, B. J. (2021). Death by political party: The relationship between COVID-19 deaths and political party affiliation in the United States. World Medical & Health Policy, 13, 224–249.
Garibaldi, B. T., Wang, K., Robinson, M. L., Zeger, S. L., Bandeen-Roche, K., Wang, M. C., Alexander, G. C., Gupta, A., Bollinger, R., & Xu, Y. (2021). Comparison of time to clinical improvement with vs without Remdesivir treatment in hospitalized patients with COVID-19. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2021.3071
Gollwitzer, A., Martel, C., Brady, W. J., Pärnamets, P., Freedman, I. G., Knowles, E. D., & Van Bavel, J. J. (2020). Partisan differences in physical distancing are linked to health outcomes during the COVID-19 pandemic. Nature Human Behaviour, 4(11), 1186–1197.
Gupta, S., Cantor, J., Simon, K. I., Bento, A. I., Wing, C., & Whaley, C. M. (2021). Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States: Study examines role of COVID-19 vaccines and deaths averted in the United States. Health Affairs, 40, 1465–1472.
Hoffmann, M., Krüger, N., Schulz, S., Cossmann, A., Rocha, C., Kempf, A., Nehlmeier, I., Graichen, L., Moldenhauer, A. S., Winkler, M. S., & Lier, M. (2021). The Omicron variant is highly resistant against antibody-mediated neutralization–implications for control of the COVID-19 pandemic. Cell. https://doi.org/10.1016/j.cell.2021.12.032
Hsiehchen, D., Espinoza, M., & Slovic, P. (2020). Political partisanship and mobility restriction during the COVID-19 pandemic. Public Health, 187, 111–114.
Jayk Bernal, A., Gomes da Silva, M. M., Musungaie, D. B., Kovalchuk, E., Gonzalez, A., Delos Reyes, V., Martín-Quirós, A., Caraco, Y., Williams-Diaz, A., Brown, M. L., & Du, J. (2022). Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. New England Journal of Medicine, 386, 509–520.
Johns Hopkins University. (2022). Understanding vaccination progress. https://coronavirus.jhu.edu/vaccines/international. Accessed January 13, 2022.
Johnson, A. G. (2022). COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron variant emergence—25 US Jurisdictions, April 4–December 25, 2021. MMWR. Morbidity and Mortality Weekly Report, 71, 132–138.
Kaiser Family Foundation. (2021). KFF COVID-19 vaccine monitor: September 2021. https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-september-2021/
Karim, S. S. A., & Karim, Q. A. (2021). Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic. The Lancet, 398, 2126–2128.
Kates, J., Tolbert, J., & Orgera, K. (2021). The red/blue divide in COVID-19 vaccination rates. Kaiser Family Foundation (KFF). https://www.kff.org/policy-watch/the-red-blue-divide-in-covid-19-vaccination-rates/
Kreps, S. E., Goldfarb, J. L., Brownstein, J. S., & Kriner, D. L. (2021). The relationship between US adults’ misconceptions about COVID-19 vaccines and vaccination preferences. Vaccines, 9, 901. https://doi.org/10.3390/vaccines9080901
Li, G., Niu, J., Fan, X., Chen, T., & He, D. (2021). The chilly climate may increase the chance of infecting COVID-19. Journal of Infection, 82, e16–e17.
Lin, R. -G., Evans, M., & Greene, S. (2021). How Florida fell so far behind California in battling the cononavirus. Los Angeles Times, September 29 edition.
MacDonald, G. (2021). Geographic patterns of the pandemic in the United States: Covid-19 response within a disunified federal system. In Coronavirus (COVID-19) outbreaks, environment and human behaviour (pp. 451–467). Springer.
Mayo Clinic. (2022). Vaccine tracker. https://www.mayoclinic.org/coronavirus-covid-19/vaccine-tracker
Merica, D. (2021). Trump met with boos after revealing he received Covid-19 booster. CNN. https://www.cnn.com/2021/12/20/politics/donald-trump-booster-shot-boos/index.html
Moore, J. X., Gilbert, K. L., Lively, K. L., Laurent, C., Chawla, R., Li, C., Johnson, R., Petcu, R., Mehra, M., Spooner, A., & Kolhe, R. (2021). Correlates of COVID-19 vaccine hesitancy among a community sample of African Americans living in the Southern United States. Vaccines, 9, 879. https://doi.org/10.3390/vaccines9080879
Nanduri, S., Pilishvili, T., Derado, G., Soe, M. M., Dollard, P., Wu, H., Li, Q., Bagchi, S., Dubendris, H., Link-Gelles, R., & Jernigan, J. A. (2021). Effectiveness of Pfizer-BioNTech and Moderna vaccines in preventing SARS-CoV-2 infection among nursing home residents before and during widespread circulation of the SARS-CoV-2 B. 1.617. 2 (Delta) variant—National Healthcare Safety Network, March 1–August 1, 2021. Morbidity and Mortality Weekly Report, 70, 1163–1166.
Pulliam, J. R., van Schalkwyk, C., Govender, N., von Gottberg, A., Cohen, C., Groome, M. J., Dushoff, J., Mlisana, K., & Moultrie, H. (2022). Increased risk of SARSCoV-2 reinfection associated with emergence of Omicron in South Africa. Science, 376(6593), eabn4947.
Pulliam, J. R., van Schalkwyk, C., Govender, N., von Gottberg, A., Cohen, C., Groome, M. J., Dushoff, J., Mlisana, K., & Moultrie, H. (2021). Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. MedRxiv. https://doi.org/10.1101/2021.11.11.21266068v2
Ruiz, J. B., & Bell, R. A. (2021). Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey. Vaccine, 39, 1080–1086.
Self, W. H., Tenforde, M. W., Rhoads, J. P., Gaglani, M., Ginde, A. A., Douin, D. J., Olson, S. M., Talbot, H. K., Casey, J. D., Mohr, N. M., & Zepeski, A. (2021). Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions—United States, March–August 2021. Morbidity and Mortality Weekly Report, 70, 1337. https://doi.org/10.15585/mmwr.mm7038e1
Suthar, M. S., Arunachalam, P. S., Hu, M., Reis, N., Trisal, M., Raeber, O., Chinthrajah, S., Davis-Gardner, M. E., Manning, K., Mudvari, P., & Boritz, E. (2022). Durability of immune responses to the BNT162b2 mRNA vaccine. Med, 3, 25–27.
Tartof, S. Y., Slezak, J. M., Fischer, H., Hong, V., Ackerson, B. K., Ranasinghe, O. N., Frankland, T. B., Ogun, O. A., Zamparo, J. M., Gray, S., Valluri, S. R., Pan, K., Angulo, F. J., Jodar, L., & McLaughlin, J. M. (2021). Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. The Lancet, 398, 1407–1416.
Usmani, M., Jamal, Y., Gangwar, M., Magers, B., Chaves-Gonzalez, J., Wu, C. Y., Colwell, R., & Jutla, A. (2022). Asymmetric relationship between ambient air temperature and incidence of COVID-19 in the human population. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.21-0328
Walter, E. B., Talaat, K. R., Sabharwal, C., Gurtman, A., Lockhart, S., Paulsen, G. C., Barnett, E. D., Muñoz, F. M., Maldonado, Y., Pahud, B. A., & Domachowske, J. B. (2022). Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age. New England Journal of Medicine, 386, 35–46.
Weinberger, D. M., Chen, J., Cohen, T., Crawford, F. W., Mostashari, F., Olson, D., Pitzer, V. E., Reich, N. G., Russi, M., Simonsen, L., & Watkins, A. (2020). Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020. JAMA Internal Medicine, 180, 1336–1344.
White House. (2021). Path out of the pandemic: President Biden’s COVID-19 action plan. https://www.whitehouse.gov/covidplan/. Accessed January 21, 2022.
Willis, D. E., Andersen, J. A., Bryant-Moore, K., Selig, J. P., Long, C. R., Felix, H. C., Curran, G. M., & McElfish, P. A. (2021). COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear. Clinical and Translational Science, 14(6), 2200–2207.
World Health Organizatioṇ. (2020). WHO coronavirus disease (COVID-19) dashboard. https://covid19.who.int/. Accessed November 12, 2020.
Acknowledgements
We thank Professor Rais Akhtar for his kind invitation to submit this chapter. We thank two anonymous reviewers for their careful reading and very helpful comments and suggestions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
MacDonald, G.M., Longcore, T. (2022). Geographic Patterns of COVID-19 Vaccination, Infection, and Mortality in the United States During Year Two of the Pandemic and the Influence of Political Orientation. In: Akhtar, R. (eds) Coronavirus (COVID-19) Outbreaks, Vaccination, Politics and Society. Springer, Cham. https://doi.org/10.1007/978-3-031-09432-3_21
Download citation
DOI: https://doi.org/10.1007/978-3-031-09432-3_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-09431-6
Online ISBN: 978-3-031-09432-3
eBook Packages: Social SciencesSocial Sciences (R0)